Health is the lack of internal interference for life
The manufacture of the "InterChem" company was visited by a delegation of honored guests, which included Mrs. Eva Terasalmi.
On May 22, in the framework of the International Pharmaceutical Forum “World Pharmacy 2019”, a delegation of honored guests visited the production site of “InterChem”, including Mrs. Eeva Terasalmi (Finland), Vice-President of the International Pharmaceutical Federation (FIP).
The International Pharmaceutical Federation (FIP) is the global body representing pharmacy, pharmaceutical sciences and pharmaceutical education. Through 144 national organisations, academic institutional members and individual members, it represent over four million...
General Director of
General Director of InterChem Company, Candidate of Chemical Sciences, laureate of the State Prize of Ukraine in the Field of Science and Technology Anatoly Raeder Visiting Irina Kaminska.
It was about the formation of the company, about what was important earlier and now, about charity and plans for the future.
At the end of the program, Irina Kaminska noted that the InterChem company and its CEO are the real heritage of Odessa and wished to become Nobel Prize winners in the near future.
The program, which was broadcast on Dumskaya TV on...
- An exit lesson of biotechnology students in the conditions of SLC On March 18, 2019, an exit lesson of biotechnology students OS 162- “Biotechnology and Bioengineering” of III and IV courses in the conditions of SLC “InterChem” took place. At the beginning of the meeting, Igor Stelmach, Director for Production of the SLC "InterChem", made a welcoming speech. He told about the history of the creation of this enterprise, acquainted with the pharmacological products, equipment and achievements that are carried out by the enterprise. Biotechnology students of the Nikolaev National Agrarian University were...
- Information appeal regarding to the drug Amispiron IC The Pharmacovigilance Risk Assessment Committee EMA (PRAC) recommended temporarily to stop usingdrugs containing fenspiride. Suspension is a precautionary measure to protect patients during PRAC review of evidence of the risk of prolonged QT interval and torsades de pointes (disturbances in the electrical activity of the heart, which may lead to disturbances in the heart rhythm). On the basis of PRAC data and in accordance to the legislation of Ukraine, the State Drugs and Medication Central Service of Ukraine temporarily stop the sale and...
- Information of the State Expert Center of the MoH Ukraine about the drugs which contain fenspiridum, in the EU EMA’s safety committee (PRAC) has recommended an EU-wide suspension of fenspiride medicines, used in children and adults to relieve cough caused by lung diseases. The suspension is a precautionary measure to protect patients while the PRAC reviews the risk of QT prolongation and torsades de pointes (abnormalities of the heart’s electrical activity that may lead to heart rhythm disturbances). Cases of heart rhythm problems had been reported in patients who had taken these medicines in the past. To explore the potential link between...